We are live on ! Find out more
BFEC

Benjamin F. Edwards & Company Portfolio holdings

AUM $5.69B
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+15.37%
3 Year Est. Return
+19.73%
5 Year Est. Return
+83.07%
10 Year Est. Return
+162.03%
AUM
$1.19B
AUM Growth
+$88.2M
Cap. Flow
+$56.7M
Cap. Flow %
4.75%
Top 10 Hldgs %
20.13%
Holding
2,021
New
301
Increased
667
Reduced
426
Closed
97
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CG icon
1476
Carlyle Group
CG
$17.6B
$8K ﹤0.01%
340
-355
-51% -$7.3K
CORP icon
1477
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.6B
$8K ﹤0.01%
+71
New +$7.42K
CTBI icon
1478
Community Trust Bancorp
CTBI
$1.39B
$8K ﹤0.01%
180
EIDO icon
1479
iShares MSCI Indonesia ETF
EIDO
$490M
$8K ﹤0.01%
325
ELAN icon
1480
Elanco Animal Health
ELAN
$12B
$8K ﹤0.01%
+234
New +$7.6K
FCG icon
1481
First Trust Natural Gas ETF
FCG
$670M
$8K ﹤0.01%
530
-623
-54% -$9.83K
FNLC icon
1482
First Bancorp
FNLC
$391M
$8K ﹤0.01%
+288
New +$7.44K
GOAU icon
1483
US Global GO Gold and Precious Metal Miners ETF
GOAU
$217M
$8K ﹤0.01%
578
HTGC icon
1484
Hercules Capital
HTGC
$3.28B
$8K ﹤0.01%
600
ING icon
1485
ING
ING
$101B
$8K ﹤0.01%
727
INVH icon
1486
Invitation Homes
INVH
$17.4B
$8K ﹤0.01%
304
LAD icon
1487
Lithia Motors
LAD
$8.16B
$8K ﹤0.01%
69
CALY
1488
Callaway Golf Company
CALY
$2.82B
$8K ﹤0.01%
+485
New +$8.01K
NBIX icon
1489
Neurocrine Biosciences
NBIX
$15.6B
$8K ﹤0.01%
+100
New +$8.21K
NHI icon
1490
National Health Investors
NHI
$3.55B
$8K ﹤0.01%
100
-100
-50% -$7.77K
NHTC icon
1491
Natural Health Trends
NHTC
$14.1M
$8K ﹤0.01%
1,023
PGF icon
1492
Invesco Financial Preferred ETF
PGF
$659M
$8K ﹤0.01%
438
+6
+1% +$111
PIE icon
1493
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$255M
$8K ﹤0.01%
436
-435
-50% -$7.37K
PRO
1494
DELISTED
PROS Holdings
PRO
$8K ﹤0.01%
+119
New +$6.26K
PSMT icon
1495
Pricesmart
PSMT
$5.21B
$8K ﹤0.01%
+159
New +$8.87K
PXE icon
1496
Invesco Energy Exploration & Production ETF
PXE
$86.3M
$8K ﹤0.01%
465
REGN icon
1497
Regeneron Pharmaceuticals
REGN
$81.5B
$8K ﹤0.01%
25
SLF icon
1498
Sun Life Financial
SLF
$43.8B
$8K ﹤0.01%
186
VDC icon
1499
Vanguard Consumer Staples ETF
VDC
$7.93B
$8K ﹤0.01%
56
WGO icon
1500
Winnebago Industries
WGO
$858M
$8K ﹤0.01%
213
+1
+0.5% +$35

Similar funds

Benjamin F. Edwards & Company's Q2 2019 Portfolio in Review

As of Q2 2019, Benjamin F. Edwards & Company held 2,021 positions worth $1.19B, up 8% from $1.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Benjamin F. Edwards & Company deployed $56.7M of net new capital in Q2 2019, opening 301 new positions and adding to 667 existing holdings. Its largest new stake was VictoryShares Emerging Market High Div Volatility Wtd ETF: 51,087 shares worth $1.25M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, down from 61% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Invesco BulletShares 2019 Corporate Bond ETF, an estimated $12.9M trimmed.

  • Benjamin F. Edwards & Company's largest Q2 2019 buy was VictoryShares Emerging Market High Div Volatility Wtd ETF: 51,087 shares worth $1.25M.
  • Benjamin F. Edwards & Company added most to iShares 20+ Year Treasury Bond ETF in Q2 2019, an estimated $10.3M increase.
  • Benjamin F. Edwards & Company's biggest Q2 2019 reduction was Invesco BulletShares 2019 Corporate Bond ETF, cutting an estimated $12.9M.
  • Benjamin F. Edwards & Company fully exited Franklin Universal Trust in Q2 2019, selling an estimated $1.11M.
  • Benjamin F. Edwards & Company's ten largest holdings make up 20% of its $1.19B portfolio in Q2 2019.
  • Benjamin F. Edwards & Company opened 301 new positions and closed 97 in Q2 2019.
  • Benjamin F. Edwards & Company's portfolio value rose 8% quarter-over-quarter to $1.19B.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2019, filed 8 Aug 2019.